These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29034775)

  • 1. Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma.
    Hong YM; Cho M; Yoon KT; Chu CW; Yang KH; Park YM; Rhu JH
    Tumour Biol; 2017 Oct; 39(10):1010428317720863. PubMed ID: 29034775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.
    Nanashima A; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Tsuji T; Hidaka S; Sawai T; Yasutake T; Nakagoe T
    Eur J Surg Oncol; 2003 Nov; 29(9):735-42. PubMed ID: 14602492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    J Surg Oncol; 2010 Oct; 102(5):462-8. PubMed ID: 20872949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival: a preliminary evaluation of an improved assay for PIVKA-II.
    Nanashima A; Abo T; Taura N; Shibata H; Ichikawa T; Takagi K; Arai J; Oyama S; Nagayasu T
    Anticancer Res; 2013 Jun; 33(6):2689-97. PubMed ID: 23749928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
    Hirokawa F; Hayashi M; Asakuma M; Shimizu T; Inoue Y; Uchiyama K
    Surg Oncol; 2016 Mar; 25(1):24-9. PubMed ID: 26979637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma.
    Kim JM; Hyuck C; Kwon D; Joh JW; Lee JH; Paik SW; Park CK
    World J Surg; 2013 Jun; 37(6):1371-8. PubMed ID: 23443153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas.
    Wang BL; Tan QW; Gao XH; Wu J; Guo W
    Asian Pac J Cancer Prev; 2014; 15(16):6673-8. PubMed ID: 25169507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
    Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
    Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
    Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
    J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
    Kim H; Park MS; Park YN; Kim H; Kim KS; Choi JS; Ahn SH; Han KH; Kim MJ; Kim KW
    Yonsei Med J; 2009 Dec; 50(6):789-95. PubMed ID: 20046419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M; Nakashima Y; Nakashima O; Kojiro M
    Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm.
    Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Tomonaga H; Higuchi T; Shimokawa M; Shirabe K
    Int J Clin Oncol; 2024 Aug; 29(8):1182-1190. PubMed ID: 38769190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recurrence after curative resection in oligonodular hepatocellular carcinoma.
    Huang L; Li J; Yan J; Cao J; Liu C; Zhang X; Wu M; Yan Y
    Hepatogastroenterology; 2013; 60(121):28-31. PubMed ID: 22945337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
    Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
    J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.
    Shimada S; Kamiyama T; Yokoo H; Orimo T; Wakayama K; Einama T; Kakisaka T; Kamachi H; Taketomi A
    World J Surg; 2017 Aug; 41(8):2087-2094. PubMed ID: 28271260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
    Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
    J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.